See the published version of this preprint at BMC Oral Health.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
Research article
A lum Han
Wonkwang University Hospital, Iksan
Corresponding Author
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: The accurate documentation of a patient’s prior medication use by dentists, and their knowledge of the side effects associated with anti-osteoporotic agents can prevent medication-related osteonecrosis of the jaws. This study investigated the awareness of dentists regarding medication-related osteonecrosis of the jaws, with the aim of determining the need for targeted educational interventions for this medical condition within the dental profession.
Methods: An online questionnaire survey was conducted among 1000 dentists registered in an online community in Korea.
Results: Dentists who documented the use of anti-osteoporotic medications by patients were more likely to have no prior experience of encountering previous cases of medication-related osteonecrosis of the jaws; this was evident among dentists who documented the names of these medications (97.5% having no experience versus 95.6% having experience; P = 0.116), and those who recorded both medication names and duration of use (67.5% having no experience versus 59.0% having experience; P = 0.007). In terms of dentists who advised drug holidays for ≥6 months, the proportion with no prior experience of medication-related osteonecrosis of the jaws was also higher than the proportion with prior experience (42.1% versus 32.8%, respectively; P < 0.001).
Conclusions: These results suggest that dentists do not respond consistently to the patient's drug history prior to performing dental procedures. This implies the need for mutual cooperation between dentists and physicians, and the development of targeted educational interventions for the dental profession.
Trial registration: Not applicable.
Keywords
awareness, dentists, education, osteoporosis
This is a list of supplementary files associated with this preprint. Click to download.
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at BMC Oral Health.
No community comments so far
Review #1 received
Received 04 Feb, 2021
Reviewer #2 agreed
On 21 Jan, 2021
Reviewers invited
Invitations sent on 18 Jan, 2021
Reviewer #1 agreed
On 18 Jan, 2021
Editor assigned
On 17 Jan, 2021
Submission checks complete
On 17 Jan, 2021
Editor invited
On 17 Jan, 2021
Version 1
Posted 04 Dec, 2020
No comments provided
Editorial decision: Major revision
On 26 Dec, 2020
Review #1 received
Received 25 Dec, 2020
Review #2 received
Received 18 Dec, 2020
Reviewer #2 agreed
On 13 Dec, 2020
Reviewer #1 agreed
On 06 Dec, 2020
Editor assigned
On 24 Nov, 2020
Reviewers invited
Invitations sent on 24 Nov, 2020
Submission checks complete
On 24 Nov, 2020
Editor invited
On 24 Nov, 2020
First submitted
On 16 Nov, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Dentistry
Learn more about our company.
A new preprint design is coming!
We have improved readability, clarity, accessibility, and opportunities for engagement.
See the published version of this preprint at BMC Oral Health.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research article
A lum Han
Wonkwang University Hospital, Iksan
Corresponding Author
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at BMC Oral Health.
No community comments so far
Review #1 received
Received 04 Feb, 2021
Reviewer #2 agreed
On 21 Jan, 2021
Reviewers invited
Invitations sent on 18 Jan, 2021
Reviewer #1 agreed
On 18 Jan, 2021
Editor assigned
On 17 Jan, 2021
Submission checks complete
On 17 Jan, 2021
Editor invited
On 17 Jan, 2021
Version 1
Posted 04 Dec, 2020
No comments provided
Editorial decision: Major revision
On 26 Dec, 2020
Review #1 received
Received 25 Dec, 2020
Review #2 received
Received 18 Dec, 2020
Reviewer #2 agreed
On 13 Dec, 2020
Reviewer #1 agreed
On 06 Dec, 2020
Editor assigned
On 24 Nov, 2020
Reviewers invited
Invitations sent on 24 Nov, 2020
Submission checks complete
On 24 Nov, 2020
Editor invited
On 24 Nov, 2020
First submitted
On 16 Nov, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Dentistry
License:
This work is licensed under a CC BY 4.0 License. Read Full License
View the published article at BMC Oral Health.
Background: The accurate documentation of a patient’s prior medication use by dentists, and their knowledge of the side effects associated with anti-osteoporotic agents can prevent medication-related osteonecrosis of the jaws. This study investigated the awareness of dentists regarding medication-related osteonecrosis of the jaws, with the aim of determining the need for targeted educational interventions for this medical condition within the dental profession.
Methods: An online questionnaire survey was conducted among 1000 dentists registered in an online community in Korea.
Results: Dentists who documented the use of anti-osteoporotic medications by patients were more likely to have no prior experience of encountering previous cases of medication-related osteonecrosis of the jaws; this was evident among dentists who documented the names of these medications (97.5% having no experience versus 95.6% having experience; P = 0.116), and those who recorded both medication names and duration of use (67.5% having no experience versus 59.0% having experience; P = 0.007). In terms of dentists who advised drug holidays for ≥6 months, the proportion with no prior experience of medication-related osteonecrosis of the jaws was also higher than the proportion with prior experience (42.1% versus 32.8%, respectively; P < 0.001).
Conclusions: These results suggest that dentists do not respond consistently to the patient's drug history prior to performing dental procedures. This implies the need for mutual cooperation between dentists and physicians, and the development of targeted educational interventions for the dental profession.
Trial registration: Not applicable.
This is a list of supplementary files associated with this preprint. Click to download.
Loading...